Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dimethyl sulphoxide (DMSO) induced serum hyperosmolality.

P Wolf, M Simon

    Clinical Biochemistry
    |August 1, 1983
    PubMed
    Summary

    Intravenous dimethyl sulfoxide (DMSO) can cause extreme serum hyperosmolality, a dangerous condition where blood becomes too concentrated. This case highlights the critical need for caution when using DMSO, especially in experimental settings.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Substrate analogue induced changes of the CO-stretching mode in the cytochrome P450cam-carbon monoxide complex.

    Biochemistry·1992
    Same author

    [Ocular manifestations in porphyria cutanea tarda].

    Orvosi hetilap·1992
    Same author

    Supercoiled DNA wraps around the bacteriophage phi 29 head-tail connector.

    Proceedings of the National Academy of Sciences of the United States of America·1992
    Same author

    Obtaining clinical information: a radiology problem with a computer-based solution.

    Radiology·1992
    Same author

    Red arrows in radiology.

    AJR. American journal of roentgenology·1992
    Same author

    Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector.

    Proceedings of the National Academy of Sciences of the United States of America·1992

    Area of Science:

    • Neurology
    • Pharmacology
    • Critical Care Medicine

    Background:

    • Intracranial pressure management is crucial in neurocritical care.
    • Dimethyl sulfoxide (DMSO) is an experimental agent with potential applications in managing neurological conditions.
    • The use of DMSO in patients with elevated intracranial pressure requires careful consideration of its physiological effects.

    Observation:

    • A patient undergoing experimental treatment for increased intracranial pressure received intravenous dimethyl sulfoxide (DMSO).
    • The patient subsequently developed a brain abscess.
    • Extreme serum hyperosmolality was observed, with osmolality reaching a peak of 717 mosmol/kg.

    Findings:

    • Intravenous administration of DMSO can lead to severe, life-threatening serum hyperosmolality.
    • The osmolality levels recorded in this case significantly exceed normal physiological ranges.
    • A potential association between DMSO-induced hyperosmolality and patient outcomes warrants further investigation.

    Implications:

    • Clinicians must exercise extreme caution when considering intravenous DMSO, particularly in patients with compromised neurological status.
    • Monitoring serum osmolality is essential during DMSO administration to detect and manage potential hyperosmolality.
    • Further research is needed to elucidate the mechanisms and clinical significance of DMSO-induced hyperosmolality in critically ill patients.

    Related Experiment Videos